US 12297203
Pyrrolopyrimidine ITK inhibitors
granted A61KA61K45/06A61P
Quick answer
US patent 12297203 (Pyrrolopyrimidine ITK inhibitors) held by Aclaris Therapeutics, Inc. expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aclaris Therapeutics, Inc.
- Grant date
- Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K45/06, A61P, A61P29/00, A61P37/00